About: Follow-up studies in COVID-19 recovered patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Follow-up studies in COVID-19 recovered patients - is it mandatory? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Follow-up studies in COVID-19 recovered patients - is it mandatory?
Creator	Cho, Ssang-Goo Kumar, Nachimuthu Senthil Kumar, Nachimuthu Vellingiri Balachandar, Balachandar, Vellingiri Devi, Mohana Kaavya, Jayaramayya Mahalaxmi, Iyer Reddy, Kumar Arul, Narayanasamy Devi, Subramaniam Janardhana, Subbarami Kanchana, Sivaprakash Laldinmawii, Gracy Sivaprakash, Palanisamy Vivekanandhan, Govindasamy
Source	Elsevier; Medline; PMC
abstract	Abstract The novel Coronavirus disease 2019 (COVID-19) is an illness caused due to Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The World Health Organization (WHO) has declared this outbreak a global health emergency and as on April 24, 2020, it has spread to 213 countries, with 25,91,015 confirmed cases and 742,855 cases have been recovered from COVID-19. In this dreadful situation our team has already published an article in the Science of the Total Environment, which elaborates the various aspects of the SARS-CoV-2 infection. In this situation, it is imperative to understand the possible outcome of COVID-19 recovered patients and determine if they have any other detrimental illnesses by longitudinal analysis to safeguard their life in future. It is necessary to follow-up these recovered patients and performs comprehensive assessments for detection and appropriate management towards their psychological, physical, and social realm. This urges us to suggest that it is highly important to provide counselling, moral support as well as a few recommended guidelines to the recovered patients and society to restore to normalcy. Epidemiological, clinical and immunological studies from COVID-19 recovered patients are particularly important to understand the disease and to prepare better for potential outbreaks in the future. Longitudinal studies on a larger cohort would help us to understand the in-depth prognosis as well as the pathogenesis of COVID-19. Also, follow-up studies will help us provide more information for the development of vaccines and drugs for these kinds of pandemics in the future. Hence, we recommend more studies are required to unravel the possible mechanism of COVID-19 infection and the after-effects of it to understand the characteristics of the virus and to develop the necessary precautionary measures to prevent it.
has issue date	2020-04-27(xsd:dateTime)
bibo:doi	10.1016/j.scitotenv.2020.139021
bibo:pmid	32360909
has license	els-covid
sha1sum (hex)	5218f4120ef849159cac52500c78104f5d092eab
schema:url	https://doi.org/10.1016/j.scitotenv.2020.139021
resource representing a document's title	Follow-up studies in COVID-19 recovered patients - is it mandatory?
has PubMed Central identifier	PMC7184970
has PubMed identifier	32360909
schema:publication	Sci Total Environ
resource representing a document's body	covid:5218f4120ef849159cac52500c78104f5d092eab#body_text
is schema:about of	named entity 'Journal' named entity 'COVID-19' named entity 'patients' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'AST and ALT' named entity 'liver' named entity 'biochemical' named entity 'homeostasis' named entity 'virus' named entity 'viral infections' named entity 'COVID' named entity 'infection' named entity 'ACE2' named entity 'coronaviruses' named entity 'cell death' named entity 'COVID' named entity 'COVID-19' named entity 'viral infection' named entity 'lung infection' named entity 'infection' named entity 'cardiometabolic' named entity 'viral infection' named entity 'stigmatized' named entity 'kidney' named entity 'lung' named entity 'Severe acute respiratory syndrome' named entity 'medical history' named entity 'organ damage' named entity 'COVID' named entity 'fever' named entity 'neuroinvasion' named entity 'paediatric' named entity 'troponin' named entity 'Myocarditis' named entity 'COVID' named entity 'inflammation' named entity 'infection' named entity 'infection' named entity 'virus' named entity 'vaccines' named entity 'SARS-CoV-2' named entity 'liver' named entity 'COVID' named entity 'infection' named entity 'oxygen' named entity 'GI tract' named entity 'case fatality rate' named entity 'cardiovascular systems' named entity 'COVID-19' named entity 'comorbid condition' named entity 'anosmia' named entity 'signalling pathways' named entity 'thalamus' named entity 'COVID-19' named entity 'Follow-up studies' named entity 'COVID' named entity 'COVID-19' named entity 'SARS-CoV' named entity 'viral replication' named entity 'organ damage' named entity 'COVID' named entity 'COVID' named entity 'neurodegenerative diseases' named entity 'blood clots' named entity 'WHO'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software